Status:
UNKNOWN
Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?
Lead Sponsor:
Bassem Mohamed Sieda
Conditions:
Papillary Thyroid Carcinoma
Eligibility:
All Genders
42-55 years
Phase:
NA
Brief Summary
study assigned into three groups, Group I was the control group operated by total thyroidectomy and retrospectively followed, where the other two groups Operated by Total thyroidectomy and central nec...
Detailed Description
informed consent taken, study was a prospective cohort study, with controlled group a retrospectively. patients ablated by total thyroidectomy only who failed to achieve ablation with the first dose o...
Eligibility Criteria
Inclusion
- Age ≥20 years, Histopathology proved PTC, with no lymph nodes detected (N0)
Exclusion
- Younger age ≤20 years. Prior thyroidectomy, previous radiation exposure, postoperative radioactive iodine therapy, Histopathology report of any type of malignancy other than PTC or patients did not complete their postoperative follow-up period. PTC With N1 or N2
Key Trial Info
Start Date :
November 2 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 3 2020
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT04336696
Start Date
November 2 2016
End Date
May 3 2020
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University Hospitals
Zagazig, Egypt, 13